What's more, as Moderna revealed on Monday, unwanted side-effects, which were expected to be worse than what emerges following the administration of a flu vaccine, appeared to be surprisingly mild. As previously mentioned $£billions are at stake as governments fall over themselves to buy vaccines whether they work or not, (with 90% of the population not susceptible to COVID it's simply a question of being SEEN to be doing something,) Deutsche Bank published an updated guide to where all the major vaccine projects stand just a few days ago.
The major difference between regular vaccines and these mRNA vaccines is that they don't work like the vaccines of usually do, by using dead or weakened viral genetic material to provoke an immune response.
Instead, as Businessweek noted in its 'vaccine issue' published over the summer, Moderna’s mRNA-1273 vaccine consists of a strand of mRNA that tells the body to produce the spike protein the coronavirus uses to latch on to human cells. This strand functions like one side of a zipper: the "teeth" are a sequence of chemical letters that cells read to produce the 1,273 amino acids comprising the famous protein "spikes" that the virus uses to latch on to human cells.When it works as intended, the vaccine starts producing the proteins soon after injection, prompting the immune system to react and build up protective antibodies against them
And the poisoning of humanity begins.
after the first of two doses of the Moderna COVID-19 vaccine, 80 percent of Phase 1 participants receiving the 100 microgram (mcg) dose developed systemic side effects.
After the second dose, 100% reported side effects ranging from fatigue (80 percent), chills (80 percent), headache (60 percent) and myalgia or muscle pain (53 percent).
Pfizer’s interim analysis is the smallest of the bunch, with just 32 vaccine recipients. Their success margin is seven or fewer vaccine recipients developing symptoms, compared to 25 in the control group. In the primary analysis, efficacy is set to about 60 percent, and at most, 164 volunteers will be included in that analysis.
Especially concerning are that those receiving the vaccine in these trials are young and healthy individuals who are not really at high risk of dying from COVID-19. This makes the results of these trials highly questionable in the far more vulnerable population of the elderly.
But don't worry, as nobody has ever isolated a COVID19 virus from its host cell, indeed they are so small they cannot be observed with optical instruments and have only been identied by the electro magnetic radiation they emit, thus rendering talk of "spike protiens" mere speculation because the pictures of nasty little blue balls you se in mainstream media are only computer simulations, you can be sure of one thing only. All the scaremongering reports in mainstram media are undiluted bollocks.